Showing results (131-140 of 172) with videos related to
Sort By:
Pageof 18
Journal of Neuro-Oncology|July 14, 2016
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastomaShiao-Pei Weathers, Xiaosi Han, Diane D Liu, et al.Stem Cells (Dayton, Ohio)|January 10, 2012
REST regulates oncogenic properties of glioblastoma stem cellsMohamed M Kamal, Pratheesh Sathyan, Sanjay K Singh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
CD90 Expression Controls Migration and Predicts Dasatinib Response in GlioblastomaTony Avril, Amandine Etcheverry, Raphaël Pineau, et al.Genes and Immunity|April 3, 2025
Transcript-targeted antigen mapping reveals the potential of POSTN splicing junction epitopes in glioblastoma immunotherapyZujian Xiong, Chaim T Sneiderman, Chloe R Kuminkoski, et al.Investigational New Drugs|October 28, 2017
Radiomics to predict immunotherapy-induced pneumonitis: proof of conceptRivka R Colen, Takeo Fujii, Mehmet Asim Bilen, et al.Plos One|June 10, 2010
Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapyMasayuki Nitta, David Kozono, Richard Kennedy, et al.Journal of Neurosurgery|May 10, 2024
Preoperative stereotactic radiosurgery for cerebral metastases: safe, effective, and decreases steroid dependencyArka N Mallela, Uzoma K Iheagwara, David Fogg, et al.Nature|May 17, 2023
Lysine catabolism reprograms tumour immunity through histone crotonylationHuairui Yuan, Xujia Wu, Qiulian Wu, et al.Proceedings of the National Academy of Sciences of the United States of America|December 26, 2013
miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastomaLijoy K Mathew, Nicolas Skuli, Vera Mucaj, et al.Neuro-Oncology Advances|January 11, 2021
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogramSherise D Ferguson, Tiffany R Hodges, Nazanin K Majd, et al.Pageof 18